LYNK PHARMACEUTICALS
LYNK Pharmaceuticals is a biotech company focusing on the discovery and development of novel medicines to treat oncology, immunology, and inflammatory diseases. The company was founded in 2018 and is headquartered in Hangzhou, Zhejiang, China.
LYNK PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2018-01-01
Address:
Hangzhou, Zhejiang, China
Country:
China
Website Url:
http://www.en.lynkpharma.com
Total Employee:
11+
Status:
Active
Contact:
+86 0571-8771117
Email Addresses:
[email protected]
Total Funding:
80 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Domain Not Resolving DigiCert SSL GeoTrust SSL Alibaba HiChina DNS Tengine
Similar Organizations
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Laekna Therapeutics
Laekna Therapeutics is a biotech company focusing on drug discovery and development.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Current Employees Featured
Founder
Investors List
Med-Fine Capital
Med-Fine Capital investment in Series B - LYNK Pharmaceuticals
HEDA Ventures
HEDA Ventures investment in Series B - LYNK Pharmaceuticals
Lilly Asia Ventures
Lilly Asia Ventures investment in Series B - LYNK Pharmaceuticals
Legend Capital
Legend Capital investment in Series B - LYNK Pharmaceuticals
New Alliance Capital
New Alliance Capital investment in Series B - LYNK Pharmaceuticals
Legend Capital
Legend Capital investment in Series A - LYNK Pharmaceuticals
Zheshang Industrial Group
Zheshang Industrial Group investment in Series A - LYNK Pharmaceuticals
Decheng Capital
Decheng Capital investment in Series A - LYNK Pharmaceuticals
Med-Fine Capital
Med-Fine Capital investment in Series A - LYNK Pharmaceuticals
Kaitai Capital
Kaitai Capital investment in Series A - LYNK Pharmaceuticals
Official Site Inspections
http://www.en.lynkpharma.com
Unable to get host informations!!!